What's new

Date Content
29/06/2018 News and press releases: First two CAR-T cell medicines recommended for approval in the European Union (updated)
29/06/2018 Withdrawn application: Graspa, asparaginase, Date of withdrawal: 22/06/2018, Initial authorisation (updated)
29/06/2018 Summary of opinion: RoActemra, tocilizumab, 28/06/2018, Positive (updated)
29/06/2018 Summary of opinion: Jinarc, tolvaptan, 28/06/2018, Positive (updated)
29/06/2018 News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 June 2018 (updated)
29/06/2018 Summary of opinion: CHMP post-authorisation summary of positive opinion for Inovelon (updated)
29/06/2018 News and press releases: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients (updated)
29/06/2018 Regulatory and procedural guideline: Draft qualification opinion on Cellular therapy module of the European Society for Blood & Marrow Transplantation (EBMT) Registry (updated)
29/06/2018 Periodic safety update single assessment: Carvedilol / ivabradine: List of nationally authorised medicinal products - PSUSA/00010586/201711 (updated)
29/06/2018 Orphan designation: Rufinamide for the: Treatment of Lennox-Gastaut syndrome, 20/10/2004, Positive (updated)